Richard McKilligan - 10 Dec 2021 Form 4 Insider Report for MALACHITE INNOVATIONS, INC. (RNGE)

Role
Chief Financial Officer
Signature
/s/ Richard McKilligan
Issuer symbol
RNGE
Transactions as of
10 Dec 2021
Net transactions value
$0
Form type
4
Filing time
13 Dec 2021, 08:00:10 UTC
Next filing
31 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -10,000 -100% $0.000000* 0 10 Dec 2021 Common Stock 10,000 $2.70 Direct F1, F5
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -20,000 -100% $0.000000* 0 10 Dec 2021 Common Stock 20,000 $3.40 Direct F2, F5
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -20,000 -100% $0.000000* 0 10 Dec 2021 Common Stock 20,000 $2.10 Direct F3, F5
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -75,000 -100% $0.000000* 0 10 Dec 2021 Common Stock 75,000 $1.81 Direct F4, F5
transaction MLCT Stock Option (Right to Buy) Award $0 +114,769 $0.000000 114,769 10 Dec 2021 Common Stock 114,769 $0.2770 Direct F5
transaction MLCT Stock Option (Right to Buy) Award $0 +35,231 +31% $0.000000 150,000 10 Dec 2021 Common Stock 35,231 $0.2770 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 An option to purchase 10,000 shares of common stock was granted to the Reporting Person on 8/6/12, 3,333 shares vested on 1/1/13 and 1/1/14, and 3,334 shares vested on 1/1/15.
F2 The option provided for vesting in four equal semi-annual installments beginning on 7/1/15.
F3 The option provided for vesting in four equal semi-annual installments beginning on 11/21/15.
F4 The option provided for vesting in four equal semi-annual installments beginning on 6/27/18.
F5 On December 10, 2021, the issuer canceled, this option pursuant to the issuer's option exchange program, the options listed above. In exchange, the Reporting Person received a replacement option to purchase 114,769 shares at an exercise price of $0.277. This replacement option vested immediately.
F6 On December 10, 2021, the Reporting Person was granted options to purchase 35,231 shares of common stock at an exercise price of $0.277. This option vested immediately.